Article ID Journal Published Year Pages File Type
5514954 Pesticide Biochemistry and Physiology 2017 5 Pages PDF
Abstract

•Terbuthylazine-2-hydroxy reduced growth in early life stages of marbled crayfish.•Terbuthylazine-2-hydroxy caused delay in marbled crayfish development.•Terbuthylazine-2-hydroxy caused oxidative stress.•Terbuthylazine-2-hydroxy caused histopathological changes in hepatopancreas and gill.•Terbuthylazine-2-hydroxy has not influence to marbled crayfish at real concentration.

This study assessed the chronic effects of terbuthylazine-2-hydroxy (T2H), one of the main terbuthylazine degradation products, on early life stages of marbled crayfish (Procambarus fallax f. virginalis) by means of mortality, growth rate, early ontogeny, oxidative stress, antioxidant defence and histopathology. The crayfish were exposed to four concentrations of the tested substance as follows: 0.75 μg/l (environmental concentration), 75, 375 and 750 μg/l for 62 days. Concentrations over 75 μg/l caused lower weight compared to the control group. T2H at 750 μg/l caused delay in ontogenetic development. Levels of thiobarbituric acid reactive substances and total superoxide dismutase activity were significantly (p < 0.01) lower in groups exposed to 375 and 750 μg/l T2H. Crayfish in these treatments also showed alteration of tubular system including disintegration of tubular epithelium with complete loss of structure in some places of hepatopancreas and wall thinning up to disintegration of branchial filaments with focal infiltrations of hemocytes. In conclusion, chronic terbuthylazine-2-hydroxy exposure in concentrations up 75 μg/l (100 times higher than environmental concentration) affected growth, ontogenetic development, antioxidant system, caused oxidative stress and pathological changes in hepatopancreas of early life stages of marbled crayfish.

Graphical abstractDownload high-res image (96KB)Download full-size image

Related Topics
Life Sciences Agricultural and Biological Sciences Agronomy and Crop Science
Authors
, , , , ,